EZH2, a histone methyltransferase and key epigenetic regulator, has been extensively linked to cancer progression through its role in transcriptional repression of tumor suppressor genes and promotion of cancer stem cell-like properties (Kim and Roberts, 2016). Here, PRDM9 is linked to cancer.